Osamu Kano

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Neurobiology of Depression and Anxiety in Parkinson's Disease

Osamu Kano, Ken Ikeda, Derek Cridebring et al. · Parkinson s Disease · 2011 · 109 citations · Full text

Psychiatry, Neurobiological Factor, Parkinson Disease +15

Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients

Hazuki Watanabe, Ryoichi Nakamura, Akihiro Hirakawa et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2014 · 94 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Aging +15

Cardiovascular Risk and Neuroradiological Profiles in Asymptomatic Vertebrobasilar Dolichoectasia

Ken Ikeda, Yoshikazu Nakamura, Takehisa Hirayama et al. · Cerebrovascular Diseases · 2010 · 82 citations

Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms

Osamu Kano, Kazunori Tanaka, Takuya Kanno et al. · Scientific Reports · 2018 · 80 citations · Full text